Octopus Biosafety (STU:OCR) Notes Receivable: €0.00 Mil (As of Dec. 2024)


STU:OCR Octopus Biosafety STU:OCR
10 GF Score
Price €0.10
GF Value €0.04
! 2 Warning Signs
View Full Analysis

What is Octopus Biosafety Notes Receivable?

Octopus Biosafety STU:OCR 10 Notes Receivable is €0.00 Mil as of Dec. 2024. GuruFocus rates STU:OCR with a GF Score™ of 10/100 and a GF Value™ of €0.04. The stock has 2 warning signs investors should review.

Octopus Biosafety's Notes Receivable for the quarter that ended in Dec. 2024 was €0.00 Mil.

Octopus Biosafety Notes Receivable Related Terms

Octopus Biosafety Notes Receivable Historical Data

* Premium members only.

The historical data trend for Octopus Biosafety's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Octopus Biosafety Notes Receivable Chart

Octopus Biosafety Annual Data
Trend Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Octopus Biosafety Semi-Annual Data
Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:OCR
10GF Score
Octopus Biosafety STU:OCR
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Octopus Biosafety Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of €0.00 Mil mean?
Octopus Biosafety (STU:OCR) has a Notes Receivable of €0.00 Mil as of Dec. 2024. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Octopus Biosafety and its competitors.
Is Octopus Biosafety's Notes Receivable too high?
Octopus Biosafety's current Notes Receivable is €0.00 Mil. Overall, Octopus Biosafety has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's Notes Receivable compare to SNDK and DELL?
Octopus Biosafety's Notes Receivable of €0.00 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Hardware company?
A good Notes Receivable depends on the Hardware industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Octopus Biosafety and its competitors. Octopus Biosafety's current Notes Receivable is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current Notes Receivable of €0.00 Mil. The stock's GF Value™ is €0.04, compared to a current price of €0.10 — trading 150% above its estimated fair value. The current Notes Receivable is €0.00 Mil. Octopus Biosafety's overall GF Score™ is 10/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current Notes Receivable is €0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Octopus Biosafety (STU:OCR) Overvalued in 2026?

Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued. The current stock price of €0.10 is trading 150% above its estimated GF Value™ of €0.04.

Key valuation signals for STU:OCR:

  • Notes Receivable: €0.00 Mil
  • GF Value™: €0.04 vs. price of €0.10 (150% above fair value)
  • GF Score™: 10/100 with 2 warning signs

No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Octopus Biosafety Business Description

Other Exchanges MLOCT:France
Address 29 rue Saint Pierre, Cholet, FRA, 49300
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
10GF Score

Get the complete analysis for STU:OCR

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.04
GF Value